Related Experiment Video
Updated: Jan 27, 2026

Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
Nagavalli Somasundaram1, Jing Quan Lim2, Choon Kiat Ong3,2,4
1Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore. nagavalli.somasundaram@singhealth.com.sg.
Abstract:
Natural killer T cell lymphoma (NKTL) is an aggressive disease with very poor treatment outcomes in the advanced stages. With chemotherapy, initial response rates to treatment are high but responses are short lived. A better understanding of the complex molecular pathogenesis of this disease is essential in order to design and develop better therapeutics with improved efficacy. This review aims to summarise the key pathogenic mechanisms in NKTL which may have significant prognostic and therapeutic implications.
Insights
Natural killer T cell lymphoma (NKTL) is aggressive, with poor outcomes. Understanding its molecular causes is key to developing effective treatments for this challenging cancer.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Natural killer T cell lymphoma (NKTL) presents as an aggressive hematologic malignancy.
- Advanced-stage NKTL is associated with extremely poor prognoses and limited therapeutic options.
- Current chemotherapy yields high initial response rates, but these are often transient, highlighting unmet clinical needs.
Purpose of the Study:
- To review the intricate molecular pathogenesis of NKTL.
- To identify key pathogenic mechanisms with potential prognostic and therapeutic implications.
- To provide a foundation for the development of novel, more effective NKTL therapies.
Main Methods:
- Literature review of scientific articles on NKTL.
- Synthesis of information on molecular pathways involved in NKTL development and progression.
- Analysis of potential therapeutic targets based on pathogenic mechanisms.
Main Results:
- NKTL pathogenesis involves complex molecular alterations.
- Specific molecular pathways are implicated in disease aggressiveness and treatment resistance.
- Understanding these mechanisms offers insights into potential therapeutic strategies.
Conclusions:
- Elucidating NKTL's molecular pathogenesis is crucial for improving patient outcomes.
- Targeting identified pathways may lead to more durable responses and better efficacy.
- Further research into NKTL molecular drivers is warranted for therapeutic advancements.
Related Concept Videos
What is Natural Selection?
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Nature and Nurture
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

